GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BioInvent International BINV.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

2.95

+18.47%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 226.5m

FY2016FY2025

Net income

−SEK 332.9m

FY2016FY2025

Free cash flow

−SEK 255.0m

FY2016FY2025

Shareholders' equity

SEK 557.6m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2020FY2019FY2018FY2017FY2016
RevenueSEK 226.5mSEK 44.7mSEK 71.5mSEK 326.1mSEK 147.4mSEK 93.7mSEK 38.5mSEK 45.0mSEK 71.3m
Gross profitSEK 226.5mSEK 44.7mSEK 71.5mSEK 326.1mSEK 147.4mSEK 93.7mSEK 38.5mSEK 42.1mSEK 70.3m
Research and developmentSEK 504.2mSEK 457.7mSEK 390.4mSEK 325.9mSEK 191.4mSEK 207.9mSEK 140.2mSEK 109.7mSEK 99.5m
Operating income−SEK 351.4m−SEK 471.1m−SEK 369.9m−SEK 50.9m−SEK 76.0m−SEK 138.2m−SEK 123.2m−SEK 100.6m−SEK 62.9m
Net income−SEK 332.9m−SEK 429.4m−SEK 330.3m−SEK 34.1m−SEK 76.7m−SEK 139.1m−SEK 123.2m−SEK 100.5m−SEK 62.6m
Diluted earnings per share-5.05-6.54-5.02-0.52-2.33-6.44-8.10-8.04-5.37

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 671.2mSEK 989.2mSEK 1.40bnSEK 1.71bnSEK 802.6mSEK 226.1mSEK 120.4mSEK 170.0mSEK 276.3m
Cash and short-term investmentsSEK 592.7mSEK 867.2mSEK 1.07bnSEK 1.02bnSEK 729.3mSEK 154.0mSEK 68.9mSEK 133.8mSEK 226.1m
Total liabilitiesSEK 113.6mSEK 103.4mSEK 90.5mSEK 106.1mSEK 59.1mSEK 56.7mSEK 32.8mSEK 39.8mSEK 45.9m
DebtSEK 8.5mSEK 17.4mSEK 23.2mSEK 27.0mSEK 11.6mSEK 15.5m———
Shareholders' equitySEK 557.6mSEK 885.8mSEK 1.31bnSEK 1.61bnSEK 743.5mSEK 169.4mSEK 87.6mSEK 130.2mSEK 230.4m
Shares outstanding66m66m66m65m33m22m15m12m12m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 247.8m−SEK 380.5m−SEK 341.7m−SEK 41.2m−SEK 62.6m−SEK 125.4m−SEK 141.4m−SEK 75.9m−SEK 72.0m
Capital spending−SEK 7.3m−SEK 10.0m−SEK 13.3m−SEK 12.4m−SEK 6.7m−SEK 3.8m−SEK 3.8m−SEK 16.5m−SEK 5.3m
Free cash flow−SEK 255.0m−SEK 390.5m−SEK 355.0m−SEK 53.6m−SEK 69.3m−SEK 129.3m−SEK 145.2m−SEK 92.4m−SEK 77.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 12.8mSEK 13.4mSEK 3.0mSEK 3.3mSEK 198.1mSEK 22.1mSEK 21.4mSEK 12.8m
Gross profit—SEK 13.4mSEK 3.0m—SEK 198.1mSEK 22.1mSEK 21.4mSEK 12.8m
Operating income−SEK 125.0m−SEK 121.8m−SEK 129.4m−SEK 133.9mSEK 34.1m−SEK 122.8m−SEK 125.9m−SEK 107.1m
Net income−SEK 122.9m−SEK 119.2m−SEK 125.8m−SEK 129.2mSEK 38.8m−SEK 116.6m−SEK 116.9m−SEK 97.2m
Diluted earnings per share-1.87-1.81-1.91-1.960.59-1.77-1.78-1.48
Cash from operations−SEK 111.0m−SEK 132.0m−SEK 90.0m−SEK 103.0mSEK 66.0m−SEK 119.0m−SEK 98.0m−SEK 97.0m
Capital spending——−SEK 1.0m−SEK 1.0m−SEK 1.0m−SEK 2.0m—−SEK 1.0m
Free cash flow——−SEK 91.0m−SEK 104.0mSEK 65.0m−SEK 121.0m—−SEK 98.0m
Total assetsSEK 423.9mSEK 535.0mSEK 671.2mSEK 785.8mSEK 916.7mSEK 862.8mSEK 989.2mSEK 1.09bn
Cash and short-term investmentsSEK 340.8mSEK 456.5mSEK 592.7mSEK 690.5mSEK 797.5mSEK 742.2mSEK 867.2mSEK 950.1m
DebtSEK 8.8mSEK 5.5mSEK 8.5mSEK 10.7mSEK 22.1mSEK 24.4mSEK 17.4mSEK 17.0m
Shareholders' equitySEK 317.3mSEK 439.1mSEK 557.6mSEK 683.0mSEK 810.7mSEK 769.7mSEK 885.8mSEK 1.00bn

Financial ratios

Data as of 2 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin100.0%100.0%100.0%100.0%100.0%100.0%
Operating margin-155.1%-959.3%-461.0%-12.8%-1433.8%-51.6%
Net margin-147.0%-960.9%-462.2%-10.5%-1439.1%-52.0%
Return on equity-59.7%-48.5%-25.2%-2.1%-20.4%-10.3%
Return on assets-49.6%-43.4%-23.6%-2.0%-19.3%-9.6%
Free cash flow yield-67.2%-103.9%-91.9%-8.2%-79.1%-31.3%
Revenue growth406.9%-37.5%-78.1%1582.4%-86.8%57.2%
Earnings growth-22.5%30.0%869.1%-87.8%263.9%-44.9%
Current ratio5.67x9.91x14.93x12.41x18.98x14.45x
Debt to equity0.01x0.01x0.01x0.01x0.01x0.01x
Equity ratio83.1%89.5%93.5%93.8%94.5%92.6%
Interest coverage-874.11x-772.41x-516.40x-64.39x-537.58x-226.18x
R&D as a share of sales222.6%1024.3%546.4%99.9%1332.7%129.9%
Buybacks as a share of market value-0.3%0.2%-1.3%-20.0%-64.7%-52.3%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-11.4%9.0%30.4%
Operating income90.4%35.8%14.0%
Net income113.7%34.1%13.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin100.0%100.0%100.0%99.5%
Operating margin-303.3%-185.9%-191.2%-192.5%
Net margin-281.1%-168.5%-177.4%-181.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-1.6-1.6-1.0-16.9-2.5-5.4-1.3-1.6-1.7-3.9
Price to sales2.415.64.81.835.62.81.95.13.93.4

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 25-to-1 reverse split · 14 Dec 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.